Clinical Trial: Exploratory Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease

U.S., Nov. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07911670) titled 'Exploratory Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease' on Oct. 28.

Brief Summary: This clinical study is designed to explore the safety and tolerability of UX-DA003. It will also explore if UX-DA003 works to improve motor function in subjects with Parkinson's disease.

Study Start Date: Nov. 23

Study Type: INTERVENTIONAL

Condition: PARKINSON DISEASE (Disorder)

Intervention: DRUG: UX-DA003

UX-DA003 (Human Allogeneic iPSC-derived Midbrain Dopaminergic Progenitor cells) is used for treating patients with PD via implanting into bilateral putamina under stereotactic neurosurgery.

Re...